Levetiracetam
NDC Package 51672-4142-0
Package Information
Levetiracetam is used to treat seizures (epilepsy). Marketed by Sun Pharmaceutical Industries, Inc., this product is identified by NDC 51672-4142 and is authorized under FDA application ANDA078960.
Identification & Billing
- RxCUI: 311288 - levETIRAcetam 250 MG Oral Tablet
- RxCUI: 311288 - levetiracetam 250 MG Oral Tablet
- RxCUI: 311289 - levETIRAcetam 500 MG Oral Tablet
- RxCUI: 311289 - levetiracetam 500 MG Oral Tablet
- RxCUI: 311290 - levETIRAcetam 750 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 51672 - Sun Pharmaceutical Industries, Inc.
- 51672-4142 - Levetiracetam
- 51672-4142-0 - 10 BLISTER PACK in 1 CARTON / 10 TABLET, FILM COATED in 1 BLISTER PACK
- 51672-4142 - Levetiracetam
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (51672-4142). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 51672-4142-0 identifies a specific commercial package of 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack of Levetiracetam, labeled by Sun Pharmaceutical Industries, Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Sun Pharmaceutical Industries, Inc. on February 01, 2010. The current certification is valid through February 01, 2010.
What are the primary indications for this medication?
Levetiracetam is used to treat seizures (epilepsy). It belongs to a class of drugs known as anticonvulsants. Levetiracetam may decrease the number of seizures you have.
How is this Sun Pharmaceutical Industries, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 51672414200. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.